Column Capital Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$29.1K Sell
167
-1
-0.6% -$182 ﹤0.01% 390
2023
Q2
$28.9K Sell
168
-5
-3% -$864 ﹤0.01% 394
2023
Q1
$28.8K Hold
173
– – ﹤0.01% 397
2022
Q4
$25.4K Hold
173
– – ﹤0.01% 389
2022
Q3
$26K Buy
173
+7
+4% +$1.17K 0.01% 356
2022
Q2
$29K Sell
166
-1,473
-90% -$255K 0.01% 348
2022
Q1
$309K Sell
1,639
-9
-0.5% -$1.78K 0.06% 96
2021
Q4
$402K Sell
1,648
-52
-3% -$11.4K 0.08% 83
2021
Q3
$330K Sell
1,700
-38
-2% -$7.67K 0.07% 87
2021
Q2
$324K Sell
1,738
-34
-2% -$5.91K 0.07% 84
2021
Q1
$279K Sell
1,772
-917
-34% -$145K 0.06% 91
2020
Q4
$445K Sell
2,689
-102
-4% -$16.6K 0.11% 64
2020
Q3
$462K Sell
2,791
-39
-1% -$5.99K 0.14% 52
2020
Q2
$387K Buy
2,830
+382
+16% +$49.9K 0.13% 54
2020
Q1
$288K Sell
2,448
-85
-3% -$11.2K 0.12% 58
2019
Q4
$335K Buy
+2,533
New +$315K 0.17% 60

Other funds holding ZTS

Column Capital Advisors's ZTS Position: Q3 2023 in Review

Column Capital Advisors reduced its Zoetis (ZTS) stake by 0.6% in Q3 2023, selling an estimated $182 and leaving 167 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Column Capital Advisors first reported a position in ZTS in Q4 2019 and has held it in 16 quarters since. The position peaked at $462K in Q3 2020. 1,628 funds tracked by Wall St. Rank hold ZTS as of Q3 2023.

  • Column Capital Advisors held 167 shares of Zoetis worth $29.1K as of Q3 2023.
  • Column Capital Advisors sold 1 Zoetis share in Q3 2023, an estimated $182.
  • Zoetis made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #390 holding.
  • Column Capital Advisors first reported a position in Zoetis in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's Zoetis position peaked at $462K in Q3 2020.
  • 1,628 funds tracked by Wall St. Rank held Zoetis as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.